Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Sci Rep] 2024 Jun 22; Vol. 14 (1), pp. 14409. <i>Date of Electronic Publication: </i>2024 Jun 22.
- MeSH Terms: Diabetes Mellitus, Type 2* ; Biomarkers* / blood ; Machine Learning* ; Oxidative Stress* ; Humans ; Male ; Female ; Middle Aged ; Risk Assessment / methods ; Risk Factors ; Blood Glucose / analysis ; Blood Glucose / metabolism ; Inflammation ; Algorithms
- References: DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 2015(1), 1–22 (2015). ; Safiri, S. et al. Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990–2019: Results from the global Burden of disease study 2019. Front. Endocrinol. (Lausanne) 13, 1–14 (2022). (PMID: 10.3389/fendo.2022.838027) ; Jelinek, H. F., Stranieri, A., Yatsko, A. & Venkatraman, S. Data analytics identify glycated haemoglobin co-markers for type 2 diabetes mellitus diagnosis. Comput. Biol. Med. 75, 90–97 (2016). (PMID: 10.1016/j.compbiomed.2016.05.00527268735) ; Mahat, R. K., Singh, N., Arora, M. & Rathore, V. Health risks and interventions in prediabetes: A review. Diabetes Metab. Syndr. Clin. Res. Rev. 13, 2803–2811 (2019). (PMID: 10.1016/j.dsx.2019.07.041) ; Yaribeygi, H., Sathyapalan, T., Atkin, S. L. & Sahebkar, A. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid. Med. Cell Longev. 2020 (2020). ; Sangwung, P., Petersen, K. F., Shulman, G. I. & Knowles, J. W. Potential role of alterations in mitochondrial function in the pathogenesis of insulin resistance and type 2 diabetes. Endocrinology (United States) 161, 1–10. https://doi.org/10.1210/ENDOCR/BQAA017 (2021). (PMID: 10.1210/ENDOCR/BQAA017) ; Oguntibeju, O. O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int. J. Physiol. Pathophysiol. Pharmacol. 11, 45–63 (2019). (PMID: 313338086628012) ; Voigt, A. & Jelinek, H. F. Humanin: A mitochondrial signaling peptide as a biomarker for impaired fasting glucose-related oxidative stress. Physiol. Rep. 4, 1–5 (2016). (PMID: 10.14814/phy2.12796) ; Jelinek, H. F., Helf, C. & Khalaf, K. Human SHC-transforming protein 1 and its isoforms p66shc: A novel marker for prediabetes. J. Diabetes Investig. https://doi.org/10.1111/JDI.13551 (2021). (PMID: 10.1111/JDI.13551337593778504898) ; Maschirow, L., Khalaf, K., Al-Aubaidy, H. A. & Jelinek, H. F. Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes: Biomarkers as a possible tool for early disease detection for rural screening. Clin. Biochem. 48, 581–585 (2015). (PMID: 10.1016/j.clinbiochem.2015.02.01525753569) ; Jacob, S. M., Raimond, K. & Kanmani, D. Associated machine learning techniques based on diabetes based predictions, in 2019 International Conference on Intelligent Computing and Control Systems, ICCS 2019 1445–1450 (2019) https://doi.org/10.1109/ICCS45141.2019.9065411 . ; Early Classification of Diabetes | Kaggle. https://www.kaggle.com/datasets/andrewmvd/early-diabetes-classification . ; Paleczek, A., Grochala, D. & Rydosz, A. Artificial breath classification using xgboost algorithm for diabetes detection. Sensors 21, 745 (2021). (PMID: 10.3390/s21124187) ; Zeng, H. et al. Metabolic Biomarkers for Prognostic Prediction of Pre-diabetes: Results from a longitudinal cohort study. Sci. Rep. 7, 1–12 (2017). (PMID: 10.1038/s41598-017-14856-1) ; Lim, H., Kim, G. & Choi, J. H. Advancing diabetes prediction with a progressive self-transfer learning framework for discrete time series data. Sci. Rep. 13 (2023). ; Fregoso-Aparicio, L., Noguez, J., Montesinos, L. & García-García, J. A. Machine learning and deep learning predictive models for type 2 diabetes: a systematic review. Diabetol Metab. Syndr. 13 (2021). ; Wee, B. F., Sivakumar, S., Lim, K. H., Wong, W. K. & Juwono, F. H. Diabetes detection based on machine learning and deep learning approaches. Multimed. Tools Appl. https://doi.org/10.1007/s11042-023-16407-5 (2023). (PMID: 10.1007/s11042-023-16407-5) ; Oikonomou, E. K. & Khera, R. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovasc. Diabetol. https://doi.org/10.1186/s12933-023-01985-3 (2023). (PMID: 10.1186/s12933-023-01985-33774957910521578) ; Elshawi, R., Al-Mallah, M. H. & Sakr, S. On the interpretability of machine learning-based model for predicting hypertension. BMC Med. Inform. Decis. Mak. 19 (2019). ; Khan, M. A. B. et al. Epidemiology of Type 2 diabetes: Global burden of disease and forecasted trends. J. Epidemiol. Glob Health 10, 107–111 (2020). (PMID: 10.2991/jegh.k.191028.001321757177310804) ; Sadeghi, S., Khalili, D., Ramezankhani, A., Mansournia, M. A. & Parsaeian, M. Diabetes mellitus risk prediction in the presence of class imbalance using flexible machine learning methods. BMC Med. Inform. Decis. Mak. 22, 1–13 (2022). (PMID: 10.1186/s12911-022-01775-z) ; Liu, L. et al. Solving the class imbalance problem using ensemble algorithm: application of screening for aortic dissection. BMC Med. Inform. Decis. Mak. 22 (2022). ; Elseddawy, A. I., Karim, F. K., Hussein, A. M. & Khafaga, D. S. Predictive analysis of diabetes-risk with class imbalance. Comput. Intell. Neurosci. 2022 (2022). ; Rezvani, S. & Wang, X. A broad review on class imbalance learning techniques. Appl. Soft Comput. https://doi.org/10.1016/j.asoc.2023.110415 (2023). (PMID: 10.1016/j.asoc.2023.110415) ; Barmparis, G. D., Marketou, M. E., Tsironis, G. P., Dritsas, E. & Trigka, M. Data-driven machine-learning methods for diabetes risk prediction. Sensors 22, 5304 (2022). (PMID: 10.3390/s22145304) ; Azad, C. et al. Prediction model using SMOTE, genetic algorithm and decision tree (PMSGD) for classification of diabetes mellitus. Multimed. Syst. 28, 1289–1307 (2022). (PMID: 10.1007/s00530-021-00817-2) ; Roy, K. et al. An enhanced machine learning framework for type 2 diabetes classification using imbalanced data with missing values. Complexity 2021 (2021). ; Feng, X., Cai, Y. & Xin, R. Optimizing diabetes classification with a machine learning-based framework. BMC Bioinform. 24 (2023). ; Tasin, I., Nabil, T. U., Islam, S. & Khan, R. Diabetes prediction using machine learning and explainable AI techniques. Healthc. Technol. Lett. 10, 1–10 (2023). (PMID: 10.1049/htl2.1203937077883) ; Bellinger, C., Sharma, S. & Japkowicz, N. One-class versus binary classification: Which and when? in Proceedings - 2012 11th International Conference on Machine Learning and Applications, ICMLA 2012 vol. 2 102–106 (2012). ; Perera, P., Oza, P. & Patel, V. M. One-class classification: A survey. (2021). ; Kang, S. Using binary classifiers for one-class classification. Expert Syst. Appl. 187 (2022). ; Seliya, N., Abdollah Zadeh, A. & Khoshgoftaar, T. M. A Literature Review on One-Class Classification and Its Potential Applications in Big Data. Journal of Big Data vol. 8 (Springer, 2021). ; López-De-Ipiña, K., Faundez-Zanuy, M., Sole, J., Zelarin, F. & Calvo, P. Multi-Class versus One-Class Classifier in Spontaneous Speech Analysis Oriented to Alzheimer Disease Diagnosis. ; Vasighizaker, A., Sharma, A. & Dehzangi, A. A novel one-class classification approach to accurately predict disease-gene association in acute myeloid leukemia cancer. PLoS ONE 14 (2019). ; Liu, X., Ouellette, S., Jamgochian, M., Liu, Y. & Rao, B. One-class machine learning classification of skin tissue based on manually scanned optical coherence tomography imaging. Sci. Rep. 13 (2023). ; Argaw, P. N., Kushner, J. A., Kohane, I. S. & Paulson, H. J. A. Unsupervised Anomaly Detection to Characterize Heterogeneity in Type 2 Diabetes. in AMIA Jt Summits Transl Sci Proc 32–41 (2023). ; Fang, J. et al. Anomaly detection of diabetes data based on hierarchical clustering and CNN. in Procedia Computer Science vol. 199 71–78 (Elsevier B.V., 2021). ; Fitriyani, N. L. et al. Prediction Model for Type 2 Diabetes using Stacked Ensemble Classifiers. in 2020 International Conference on Decision Aid Sciences and Application, DASA 2020 399–402 (Institute of Electrical and Electronics Engineers Inc., 2020). https://doi.org/10.1109/DASA51403.2020.9317090 . ; Dharmarathne, G., Jayasinghe, T. N., Bogahawaththa, M., Meddage, D. P. P. & Rathnayake, U. A novel machine learning approach for diagnosing diabetes with a self-explainable interface. Healthc. Analyt. 5 (2024). ; Hendawi, R., Li, J. & Roy, S. A mobile app that addresses interpretability challenges in machine learning–based diabetes predictions: survey-based user study. JMIR Form Res 7 (2023). ; Jakka, A. & Vakula Rani, J. An Explainable AI Approach for Diabetes Prediction. in Lecture Notes in Networks and Systems vol. 565 LNNS 15–25 (Springer Science and Business Media Deutschland GmbH, 2023). ; Jia, W. Standardising HbA1c-based diabetes diagnosis: Opportunities and challenges. Expert Rev. Mol. Diagn. 16, 343–355 (2016). (PMID: 10.1586/14737159.2016.113329926680319) ; Dorcely, B. et al. Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes Metab. Syndr. Obes. 10, 345–361 (2017). (PMID: 10.2147/DMSO.S100074288608335565252) ; Wong, C. W. Vitamin B12 deficiency in the elderly: Is it worth screening?. Hong Kong Med. J. 21, 155–164 (2015). (PMID: 25756278) ; Australian Institute of Health and Welfare. Diabetes: Australian Facts, Summary. Diabetes https://www.aihw.gov.au/reports/diabetes/diabetes/contents/summary (2023). ; Pouvreau, C., Dayre, A., Butkowski, E. G., De Jong, B. & Jelinek, H. F. Inflammation and oxidative stress markers in diabetes and hypertension. J. Inflamm. Res. 11, 61–68 (2018). (PMID: 10.2147/JIR.S148911294973245822844) ; Venkatraman, S., Yatsko, A., Stranieri, A. & Jelinek, H. F. Missing data imputation for individualised CVD diagnostic and treatment. Comput. Cardiol. 2010(43), 349–352 (2016). ; Nwose, E. U., Jelinek, H. F., Richards, R. S. & Kerr, P. G. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus. Redox Rep. 11, 99–104 (2006). (PMID: 10.1179/135100006X11658316805963) ; Zhao, J. et al. Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: A prospective study with 8-year follow-ups in two cohorts. J. Transl. Med. 17 (2019). ; Abdul-Ghani, M. A. & DeFronzo, R. A. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes care vol. 32 Suppl 2. https://doi.org/10.2337/dc09-s309 (2009). ; Ganz, M. L. et al. The association of body mass index with the risk of type 2 diabetes: A case-control study nested in an electronic health records system in the United States. Diabetol. Metab. Syndr. 6 (2014). ; Tony Liu, F., Ming Ting, K. & Zhou, Z.-H. Isolation forest ICDM08. ICDM (2008). ; Carletti, M., Terzi, M. & Susto, G. A. Interpretable anomaly detection with DIFFI: Depth-based feature importance of isolation forest. Eng. Appl. Artif. Intell. 119 (2023). ; Butkowski, E. G. & Jelinek, H. F. Hyperglycaemia, oxidative stress and inflammatory markers. Redox Rep. 22, 257–264 (2017). (PMID: 10.1080/13510002.2016.121564328277069) ; Lagman, M. et al. Investigating the causes for decreased levels of glutathione in individuals with type II diabetes. PLoS ONE 10, 1–19 (2015). (PMID: 10.1371/journal.pone.0118436) ; Al-Goblan, A. S., Al-Alfi, M. A. & Khan, M. Z. Mechanism linking diabetes mellitus and obesity. Diabetes Metab. Syndr. Obes. 7, 587–591 (2014). (PMID: 10.2147/DMSO.S67400255062344259868) ; Leitner, D. R. et al. Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies - EASO can lead the way. Obes. Facts 10, 483–492 (2017). (PMID: 10.1159/000480525290206745741209) ; Akbari, M. & Hassan-Zadeh, V. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26, 685–698. https://doi.org/10.1007/s10787-018-0458-0 (2018). (PMID: 10.1007/s10787-018-0458-029508109) ; Ene, C. V., Nicolae, I., Geavlete, B., Geavlete, P. & Ene, C. D. IL-6 Signaling link between inflammatory tumor microenvironment and prostatic tumorigenesis. Analyt. Cell. Pathol. https://doi.org/10.1155/2022/5980387 (2022). (PMID: 10.1155/2022/5980387) ; Mirmira, R. G. et al. Interleukin-6 reduces B-cell oxidative stress by linking autophagy with the antioxidant response. in Diabetes vol. 67 1576–1588 (American Diabetes Association Inc., 2018). ; Halimi, A. et al. The relation between serum levels of interleukin 10 and interferon-gamma with oral candidiasis in type 2 diabetes mellitus patients. BMC Endocr. Disord. 22 (2022). ; Ayelign, B. et al. Association of IL-10 (− 1082 A/G) and IL-6 (− 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocr. Disord. 21 (2021). ; Abhilasha et al. Downregulation of interleukin-10 receptor (IL-10R) along with low serum IL-10 levels in newly diagnosed type 2 diabetes mellitus patients. Gene Rep. 24 (2021). ; Carlini, V. et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol. https://doi.org/10.3389/fimmu.2023.1161067 (2023). (PMID: 10.3389/fimmu.2023.11610673735954910287165) ; Jelinek, H., Jamil, D. & Al-Aubaidy, H. Impaired fasting glucose & 8-iso-prostaglandin F2α in diabetes disease progression. Br. J. Med. Med. Res. 4, 5229–5237 (2014). (PMID: 10.9734/BJMMR/2014/11147) ; Schöttker, B., Xuan, Y., Gào, X., Anusruti, A. & Brenner, H. Oxidatively damaged DNA/RNA and 8-isoprostane levels are associated with the development of type 2 diabetes at older age: Results from a large cohort study. Diabetes Care 43, 130–136 (2020). (PMID: 10.2337/dc19-137931653645) ; Butkowski, E. G., Brix, L. M., Kiat, H., Al-Aubaidy, H. & Jelinek, H. F. Diabetes, oxidative stress and cardiovascular risk. Basic Res. J. Med. Clin. Sci. (2016). ; Boutari, C., Pappas, P. D., Theodoridis, T. D. & Vavilis, D. Humanin and diabetes mellitus: A review of in vitro and in vivo studies. World J. Diabetes 13, 213–223 (2022). (PMID: 10.4239/wjd.v13.i3.213354327588984571) ; Coradduzza, D. et al. Humanin and its pathophysiological roles in aging: A systematic review. Biology https://doi.org/10.3390/biology12040558 (2023). (PMID: 10.3390/biology120405583710675810135985) ; Wu, Y., Sun, L., Zhuang, Z., Hu, X. & Dong, D. Mitochondrial-derived peptides in diabetes and its complications. Front. Endocrinol. https://doi.org/10.3389/fendo.2021.808120 (2022). (PMID: 10.3389/fendo.2021.808120) ; Biondi, G. et al. The p66Shc redox protein and the emerging complications of diabetes. Int. J. Mol. Sci. https://doi.org/10.3390/ijms25010108 (2024). (PMID: 10.3390/ijms250101083889184111171768) ; Mousavi, S. et al. The role of p66Shc in diabetes: A comprehensive review from bench to bedside. Journal of Diabetes Research 20, 22. https://doi.org/10.1155/2022/7703520 (2022). (PMID: 10.1155/2022/7703520)
- Contributed Indexing: Keywords: Diabetes; Inflammation; Isolation forest; Mitochondrial dysfunction; Oxidative stress; Predictive modelling
- Substance Nomenclature: 0 (Biomarkers) ; 0 (Blood Glucose)
- Entry Date(s): Date Created: 20240622 Date Completed: 20240622 Latest Revision: 20240625
- Update Code: 20240626
- PubMed Central ID: PMC11193708
|